169 studies found for:    "psoriatic arthritis"
Show Display Options
Rank Status Study
1 Recruiting A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics
Condition: Psoriatic Arthritis
Intervention: Other: No Intervention
2 Completed Study of Psoriatic Arthritis
Conditions: Psoriasis;   Psoriatic Arthritis
Intervention:
3 Completed Metformin in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Metformin;   Drug: Placebo
4 Recruiting Psoriatic Arthritis Treat to Target vs. Usual Care
Condition: Psoriatic Arthritis (PsA)
Intervention: Other: Intensive Care
5 Enrolling by invitation The Corrona, LLC Spondyloarthritis and Psoriatic Arthritis (SpA/PsA) Registry
Conditions: Psoriatic Arthritis;   Spondyloarthritis
Intervention:
6 Completed TIght COntrol of Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Intensive management or Tight control;   Drug: Standard management - Control group
7 Completed
Has Results
REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)
Condition: Psoriatic Arthritis
Intervention: Drug: Etanercept
8 Completed Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Infliximab;   Drug: Etanercept
9 Terminated AMG 827 in Subjects With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: AMG 827;   Drug: Placebo
10 Completed Effect of Exercise and Diet on Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Other: Diet;   Other: Exercise;   Other: Diet and Exercise;   Other: Healthy Lifestyle (Control) Group
11 Not yet recruiting Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Biological: Secukinumab
12 Completed Phase II Study With CC-10004 in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: CC-10004;   Drug: Matching Placebo
13 Completed Rituxan With or Without Methotrexate in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: Rituximab
14 Recruiting Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Condition: Psoriatic Arthritis
Interventions: Drug: Tofacitinib;   Other: Placebo
15 Completed Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Biological: AIN457;   Biological: Placebo
16 Completed Differential Clinical and Serologic Response in Psoriasis and Psoriatic Arthritis to Drug Treatment
Condition: Psoriatic Arthritis
Intervention:
17 Completed Exploratory Study on Quality of Life in Patient With Moderate Psoriasis and Moderate Psoriatic Arthritis
Conditions: Psoriatic Arthritis;   Psoriasis
Intervention:
18 Recruiting A Study of Golimumab in Participants With Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Placebo;   Drug: Golimumab
19 Terminated Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: 210 mg brodalumab;   Drug: 140 mg brodalumab;   Drug: Placebo
20 Completed
Has Results
Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: etanercept

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years